Forward Pharma A/S Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BVF INC/IL | 02/14/2020 | 925,724 | $6.01 M | -85.71% | 13.63% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 02/14/2020 | 0 | $0 | 0.00% | 0.00% |
MORGAN STANLEY | 02/14/2020 | 0 | $0 | -100.00% | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 02/14/2020 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 02/14/2020 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2020 | 0 | $0 | -100.00% | 0.00% |
NEWTYN MANAGEMENT, LLC | 02/14/2020 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 02/14/2020 | 0 | $0 | -100.00% | 0.00% |
ADVISOR GROUP, INC. | 02/12/2020 | 0 | $0 | -100.00% | 0.00% |
PRIVATE CAPITAL GROUP, LLC | 02/14/2020 | 0 | $0 | -100.00% | 0.00% |
Forward Pharma A/S institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Forward Pharma A/S. The most heavily invested institutionals were:
Advisor Group, Inc.: 0
LADENBURG THALMANN FINANCIAL SERVICES INC.: 0
Financial Gravity Companies, Inc.: 16
FNY Managed Accounts LLC: 2,400
Acrospire Investment Management LLC: 0
BlackRock Institutional Trust Company, N.A.: 0
13.63% of Forward Pharma A/S stock is owned by institutional investors.
Institutional investors have bought a total of 2,416 shares in the last 24 months. This purchase volume represents approximately $4,711 in transactions.